Atorlip-F 20mg/145mg Tablet
By Atorlip-F
Rx
15 Tablet in a Strip

Composition
Atorvastatin(20mg) + Fenofibrate(145mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
May, 2026

liver
When taking Atorlip-F 20mg/145mg Tablet, it is important to be cautious if you have liver disease. Patients with liver conditions should be vigilant and may require a dose adjustment when using Atorlip-F 20mg/145mg Tablet. It is highly advised to consult your doctor before taking this medication if you have any liver issues. Avoid using Atorlip-F 20mg/145mg Tablet if you have severe liver disease as it is not recommended for such patients. Always prioritize your liver health and seek medical advice to ensure the safe use of Atorlip-F 20mg/145mg Tablet.

kidney
Atorlip-F 20mg/145mg Tablet should be used carefully in patients with kidney disease as dosage adjustment may be necessary. It is not advised for those with severe kidney disease. Please consult your doctor for guidance.

alcohol
"Caution Avoid consuming alcohol while taking Atorlip-F 20mg/145mg Tablet."

driving
When taking Atorlip-F 20mg/145mg Tablet, it is unlikely to impair your driving ability, but caution is always advised when driving.

pregnancy
Atorlip-F 20mg/145mg Tablet is not safe for use during pregnancy. Research on both pregnant women and animals has indicated potential harm to the baby. Consult your doctor before using.

breastfeeding
During breastfeeding, it is advisable to avoid using Atorlip-F 20mg/145mg Tablet as it may be unsafe. Human data indicates potential harm to the baby through breastmilk transmission.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹275.55
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024